Vials & Ampoules Manufacturing Facility, Nashik

Today, every injectable drug re­lies on a packaging system that preserves sterility, maintains chemical compatibility, withstands demanding manufacturing processes, and performs consistently throughout its shelf life.

As pharmaceutical compa­nies develop increasingly complex bi­ologics, vaccines, and specialty inject­ables, the expectations placed on glass ampoules and vials have expanded well beyond containment. Today, primary packaging has become a critical qual­ity component that directly influences manufacturing efficiency, regulatory compliance, and product integrity.

This evolving landscape has shifted the industry's focus toward manufac­turers capable of delivering precision, consistency, and pharmaceutical-grade quality at scale. Borosil Scientific has established itself in this space through its expertise in manufacturing primary pharmaceutical packaging solutions using Type I Neutral Borosilicate Glass.

By combining advanced manufactur­ing technologies with stringent qual­ity systems and regulatory readiness, the company supports pharmaceutical manufacturers with packaging solu­tions engineered to perform reliably across every stage of the drug manu­facturing lifecycle.

Precision in Every Form

For pharmaceutical packaging, consis­tency is measured in microns rather than millimetres. Even the smallest dimensional variation can disrupt fill­ing operations, compromise sealing performance, or affect product stabil­ity. Borosil Scientific addresses these challenges through fully automated, high-speed forming lines designed to produce ampoules and vials with ex­ceptional dimensional accuracy and repeatability.

“The manufacturing process is re­inforced by precision-controlled an­nealing, which systematically removes residual thermal and mechanical stresses from the glass. This improves the structural strength of each compo­nent, enabling it to withstand demand­ing pharmaceutical processes such as washing, sterilization, depyrogenation, filling, and transportation without compromising performance”, speaks Bhoomi Kotwani, Director.

Quality control is equally integral to production. Every vial and ampoule passes through European-made most precised inspection systems equipped with high-resolution cameras that perform continuous, real-time cosmetic and dimensional inspection. Critical parameters including wall thickness, overall dimensions, mouth diameter, crimp diameter, and potential defects such as micro-cracks or airlines are automatically evaluated, ensuring only compliant products move forward.

The company's expertise also ex­tends to precision-engineered One Point Cut (OPC) ampoules. Manufac­tured within tightly controlled toler­ances, these systems enable clean and reliable opening while minimizing the possibility of glass particle generation during use.

Designed for Modern Therapeutics

Borosil Scientific manufactures an extensive portfolio of pharmaceutical ampoules and vials exclusively using Type I Neutral Borosilicate Glass in both clear and amber variants. Every product is designed to comply with internationally recognized pharmacopoeial standards including USP, EP, BP, and JP, supporting pharmaceutical companies operating across regulated global markets.

Its ampoule range spans from 1 ml to 50 ml and is available in multiple ISO and DIN configurations, along with customized designs tailored to specific customer requirements. Additional options such as colour break rings, multi-colour identification bands, score lines, and One Point Cut systems provide greater flexibility for pharmaceutical manufacturers. For pH-sensitive formulations, ammonium sulphate treatment further enhances glass compatibility with sensitive drug products.

“The company's vial portfolio ranges from 1 ml to 100 ml and is engineered for liquid injectables, infusion products, and lyophilized formulations. Optional blowback profiles improve rubber stopper retention, helping maintain container closure integrity during high-speed filling operations.

Every design reflects an understanding that pharmaceutical packaging must integrate seamlessly with increasingly sophisticated production environments rather than function as a standalone component”, highlights Bhoomi Kotwani.

Quality Built Into the Process

Borosil Scientific's manufacturing philosophy extends beyond meeting specifications to embedding quality into every stage of production. Its cGMP-compliant manufacturing facility has been designed with unidirectional movement of personnel and materials to minimise contamination risks while maintaining efficient production flow.

Critical inspection, handling, testing, and packaging operations are carried out inside validated ISO Class 8 cleanrooms. These controlled environments are supported by advanced HVAC systems that regulate temperature, humidity, pressure differentials, and particulate levels, while periodic validation ensures continued compliance with ISO 14644-1 requirements.

The company's Quality Management System is certified to ISO 15378, reflecting its alignment with pharmaceutical packaging requirements. Stringent Acceptable Quality Levels are maintained for cosmetic and functional defects, with inspection criteria aligned to internationally accepted PDA defect classification guidelines.

Supporting this framework is a comprehensive laboratory equipped to perform physical and chemical evaluations, including hydrolytic resistance, glass surface testing, glass etching studies as per USP <660>, composition analysis, and break-force testing.

Every manufacturing batch is supported by complete traceability through Batch Manufacturing Records, while structured Change Control, Failure Mode and Effects Analysis (FMEA), deviation management, and Corrective and Preventive Action (CAPA) systems reinforce a culture of continuous quality improvement.

Beyond Manufacturing

Borosil Scientific's role extends beyond supplying pharmaceutical containers to support customers throughout their manufacturing and regulatory journey. To maintain the effectiveness of automated inspection systems, quality teams conduct routine challenge testing using calibrated defect masters, validating inspection performance across every production shift.

Its regulatory capabilities further strengthen this partnership. Drug Master Files are registered with the US FDA, Health Canada, and China's National Medical Products Administration, while Letters of Access are provided to support customers' regulatory submissions.

Comprehensive technical documentation, including extractables and delamination studies, validation protocols, and technical data packages, enables pharmaceutical companies to accelerate product registrations while meeting evolving global compliance requirements.

Through advanced manufacturing, rigorous quality systems, regulatory expertise, and engineering-led precision, Borosil Scientific continues to strengthen its position as a trusted manufacturer of pharmaceutical primary packaging that enables safe, reliable, and efficient drug delivery across global healthcare markets.